Viscoat Solution Ophthalmic Viscoelastic System (OVD) 0.5mL

Viscoat® Ophthalmic Viscoelastic Solution (OVD), 0.5 mL Prefilled Syringe — Alcon
Product details Description
Active ingredients Sodium chondroitin sulfate 40 mg/mL (4%) and sodium hyaluronate 30 mg/mL (3%)
Dosage form Sterile ophthalmic viscoelastic solution
Route Intraocular use during ophthalmic surgery
Size 0.5 mL single-use prefilled syringe
Manufacturer Alcon
NDC 08065-1839-05
Indications and Usage
VISCOAT® is indicated for use as an ophthalmic surgical aid in anterior segment procedures, including cataract extraction and intraocular lens (IOL) implantation. It helps maintain anterior chamber depth, improve visualization during surgery, and protect the corneal endothelium and other ocular tissues.
Dosage and Administration
For use by qualified ophthalmic surgeons during anterior segment procedures. The amount used depends on the surgical technique and the surgeon's clinical judgment. Administer intraocularly according to the manufacturer's instructions for use.
Warnings and Precautions
For intraocular surgical use by qualified ophthalmic professionals.
Follow the manufacturer's instructions for assembly and use of the supplied cannula.
Failure to follow assembly instructions or use of an alternate cannula may result in cannula detachment and potential patient injury.
Refer to the manufacturer's instructions for complete warnings and precautions.
Contraindications
Refer to the manufacturer's instructions for use for applicable contraindications and precautions.
Adverse Reactions
Potential risks are associated with intraocular surgery and the use of ophthalmic viscoelastic devices. Refer to the product's instructions for use for complete safety information.
Storage and Handling
Store according to the manufacturer's labeled storage conditions. This product may require refrigeration; verify the storage requirements on the product packaging before handling.
How Supplied
VISCOAT® Ophthalmic Viscoelastic Device is supplied as a sterile, single-use, prefilled syringe containing 0.5 mL of solution with 4% sodium chondroitin sulfate and 3% sodium hyaluronate. NDC 08065-1839-05.
Professional use only. Clinical information summarized from Alcon product information. Refer to the manufacturer's complete instructions for use for full details.
If you have any questions related to DSCSA compliance, transaction history, regulatory data or quality assurance, please contact our team at compliance@dryeyerescue.com for more information.